Assembling evidence grade
Loading
Independent evidence before payment.
GH fragment analogue · also: growth hormone fragment 176-191
AOD-9604 carries an Evidence Grade of C (Medium confidence). The strongest published evidence catalogued is human (other).
Grade C rule: At least one other human study.
The grade reflects the strength of the published evidence, not safety or efficacy. “Confidence” means how settled that grade is given the record — not how likely the compound is to work.
Human-use stop
This compound is investigational, warned or not approved for human use. A seller calling it “research only,” showing testimonials, registering a company or publishing a COA does not create an approved consumer medicine. Seller links below are market-surveillance records, not recommendations.
AOD-9604 is a growth-hormone-fragment analogue studied in human trials for weight endpoints, where results were largely unsupportive of the original hypothesis.
Animal and in-vitro results are shown separately and must never be read as established human outcomes.
In plain terms: there is 1 human study, but no randomised trial — the strongest test has not been done. Effects seen in smaller studies often do not hold up.
Strongest: randomised or pooled human trials.
none catalogued
Observational, open-label or small human studies.
Analytical approaches for the detection of emerging therapeutics and non-approved drugs in human doping controls. Journal of pharmaceutical and biomedical analysis, 2014.
Preclinical animal models — not a human outcome.
none catalogued
Cell / tissue studies — not a human outcome.
none catalogued
Proposed mechanism — hypothesis, not evidence of effect.
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. Sports medicine (Auckland, N.Z.), 2026.
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions. Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews, 2026.
Simplifying and expanding the screening for peptides <2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry. Journal of separation science, 2016.
Detecting peptidic drugs, drug candidates and analogs in sports doping: current status and future directions. Expert review of proteomics, 2014.
AOD-9604 does not influence the WADA hGH isoform immunoassay. Drug testing and analysis, 2013.
Obesity drugs in clinical development. Current opinion in investigational drugs (London, England : 2000), 2006.
Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology, 2005.
AOD-9604 Metabolic. Current opinion in investigational drugs (London, England : 2000), 2004.
Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology, 2003.
Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology, 2003.
On “cited by N”: citation counts (Crossref) reflect how often a paper has been referenced — a measure of academic attention, not of validity, safety, or whether a compound works. They do not affect the Evidence Grade, which is set purely by the strength of the evidence tier.
Pivotal human trials did not establish the hoped-for benefit. Not approved as a therapeutic.
Not an approved medicine in major markets. Sold only as a “research chemical”, with no established safe consumer use, dose or supply standard.
PepCred flags any vendor selling this compound to the public as a consumer-protection concern. Status reflects regulator records; see the regulatory detail below.
No FDA-approved (US) drug labelling found for this compound. A search of openFDA returned no approved product containing it as an active ingredient.
This reflects US FDA approval only — other regulators (e.g. MHRA, EMA) may differ; see the note below. Absence of an approved label is not, by itself, a safety finding, and a “research use only” label does not establish safety, legality or correct identity.
PepCred note: Not an approved drug. Marketed only as an unapproved 'research' peptide.
These unranked records show where the name was detected. For an investigational, warned or unapproved compound, no seller, company registration, review score or COA creates an approved human-use route.
None of these is verified for human use.